Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 563-574, August 2009

Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies

  • Elsa Sousa, MD (Rheumatology Trainee)

      Affiliations

    • Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa and Hospital de Santa Maria, Av. Professor Egas Moniz, 1649-028 Lisbon, Portugal
    • Corresponding Author InformationCorresponding author. Tel.: +351 21 7999544; Fax: +351 21 799 9412.
  • ,
  • David Isenberg, MD, FRCP, Professor

      Affiliations

    • Centre For Rheumatology Department of Medicine, University College London, London, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6942(08)00159-9

doi:10.1016/j.berh.2008.12.006

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 4 , Pages 563-574, August 2009